Article Figures & Data
Figures
- Figure 1.
Antithrombotic Use at 1 Year Based on Initial Regimen
Antithrombotic therapy use at 1 year based on initial/baseline antithrombotic regimen.
ATT, antithrombotic therapy; VKA, vitamin K antagonist; AP, antiplatelet therapy (most commonly aspirin); OAC, oral anticoagulant therapy.
Reprinted from Lip GY et al, Prognosis and treatment of atrial fibrillation patients by European cardiologists: One Year Follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry), Eur Heart J, 2014; Vol 35, Issue 47, Pages 3365-3376, by permission of Oxford University Press.
- Figure 2.
ORBIT-AF Registry: Anticoagulation According to Bleeding Risk
ATRIA indicates Anticoagulation and Risk Factors in Atrial Fibrillation; CHADS2, congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, and previous stroke or transient ischemic attack; and OAC, oral anticoagulation.
Reprinted from Steinberg BA et al. Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry, Circulation, 2014, Vol 129, Issue 20, Pages 2005-12, with permission from American Heart Association, Inc.
Tools
Table of contents
Cited By...
- No citing articles found.